Business Wire

COMTRADE-DIGITAL-SERVICE

5.12.2016 09:02:48 CET | Business Wire | Press release

Share
Comtrade Digital Services Revolutionises Payments World with Viber Banking Platform

Comtrade Digital Services , the leading software engineering services and solutions provider, today announced that it has created an automated banking platform for one of the world’s leading messaging apps, Viber. The transformative new solution is set to shake up the payments world, allowing users to carry out a range of banking transactions entirely through a chat-bot.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20161205005101/en/

With the tap of a finger, Viber users of participating banks will now be able to instantly send and transfer money. They will also be able to check their bank balance and access other banking services directly through the app. Recipients of Viber payments will be able to instantly retrieve the money sent to them by using a QR code at an ATM or going to their local branch.

Using agile methodologies, Comtrade Digital Services developed a banking solution with a chat-bot that can understand and process user requests instantly and securely. The product can be integrated directly with banks’ own digital platforms and will help them to compete with emerging Fintech companies. The solution also includes a client acquisition tool that will help banks attract younger customers, who will soon dominate the payments world. The project was completed in just three months.

The banking platform is part of Viber’s recently launched business-oriented platform, ‘Public Accounts’, which allows businesses, brands and individuals to interact with potential customers via the messaging app in a direct, personalised and intuitive manner.

Oliver Lynch, Business Development Director, Comtrade Digital Services, said: “This solution is going to transform the payments world for retail banks, payment processors and their customers. Most banks now have a mobile app, but they don’t provide such innovative, instant payment options as this. This is the only messaging platform that, through an API, can be directly integrated with banks’ existing digital banking channels.

“At Comtrade Digital Services, we are constantly telling businesses that they must be willing to embrace and drive digital transformation in order to stay ahead. That is exactly what Viber has done and I expect many will follow. This marks a whole new era of banking and we can expect a significant proportion of the world’s micro transactions to be carried out over messaging apps and social media platforms in the future.

“Now, it is time for the world’s banks to welcome this new era and seek innovative solutions that will help them retain and attract customers – or be left behind.”

Elad Kojocaru, VP Marketing, Viber, said:Viber started out as an app that connects people. Now, we are introducing a way for people to start connecting with businesses and brands through the launch of our Public Accounts service. Thanks to innovative technology partners such as Comtrade Digital Services, we enable businesses from traditional industries, such as banking, to enter the instant messaging era and interact with their customers in new ways.”

- ends -

About Comtrade Digital Services

Comtrade Digital Services is part of Comtrade Group, a leading IT provider with offices in 11 countries across Europe and North America. The group was established in 1990 and operates through 16 companies with a global staff base of over 1,500.

Comtrade Digital Services is the trusted developer of some of the world’s most renowned businesses, providing end-to-end technology products and solutions across a number of industries including government, financial institutions, healthcare, mobility, travel and logistics. By providing strategic software engineering services, Comtrade Digital Services accelerates innovation and helps companies address business challenges, embrace digital transformation and become industry leaders.

For more information on Comtrade Digital Services, visit www.comtradedigital.com

About Viber

Part of the Rakuten family, Viber freely connects users around the world with the people that matter to them most. With more than 800 million unique users on the platform, Viber allows people to connect in the way that works best for them, whether that’s through individual messaging, video calls or group chats, or following brands and celebrities on Public Accounts. Viber can be used on iPhone® , iPad® , Android™ phones and tablets, Windows Phone, Windows® , Windows 8® , Mac, and Linux devices over mobile or WiFi connections.

Contact:

For Comtrade Digital Services
Helen Morrogh
Comit Communications & Marketing
Tel: +353 1 2157677
Mob: +353 85 7814755
Email: helen@comit.ie

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

IMPACT Therapeutics and Pharmanovia Announce Positive CHMP Opinion for Senaparib, as a Potential First-Line Maintenance Treatment of Advanced High-Grade Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer18.9.2026 12:38:00 CEST | Press release

For business and medical media only This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918325771/en/ Stephan Eder, CEO, Pharmanovia IMPACT Therapeutics (07630.HK), a commercial-stage biotechnology company focused on the discovery and development of targeted anti-cancer therapeutics based on synthetic lethality mechanisms, together with global specialty pharmaceutical company Pharmanovia, today jointly announce that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion recommending the granting of a Marketing Authorisation (MA) for the medicinal product Sepalna® (senaparib) intended for the maintenance treatment of advance epithelial ovarian, fallopian tube and primary peritoneal cancer. Following the CHMP’s recommendation for approval, senaparib will be submitted to the European Commission (EC) for final decision. Once approved by the EC, senaparib will

Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital18.9.2026 11:48:00 CEST | Press release

Estithmar Holding Q.P.S.C. announced the completion of the transfer of a 48.68% stake in Shahba Bank to Masaref Holding LLC, subsidiary of Estithmar Capital, Estithmar Holding’s financial services and investments arm. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918807909/en/ Estithmar Holding Announces Completion of 48.68% Stake Transfer in Shahba Bank to Masaref Holding, a Subsidiary of Estithmar Capital (Photo: AETOSWire) As a shareholder, Masaref Holding intends to support the assessment of proposals aimed at strengthening Shahba Bank’s financial, operational and technological capabilities, including potential capital enhancement, branch network expansion, and the development of products and services for individuals, businesses and SMEs. The proposals may include modernizing banking and operational systems, develop digital services, and strengthen governance, compliance, risk management and cybersecurity to enhance

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye